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Abstract: Adult stem cells play critical roles in the basal maintenance of tissue integrity, also known
as homeostasis, and in tissue regeneration following damage. The highly conserved Wnt signalling
pathway is a key regulator of stem cell fate. In the gastrointestinal tract, Wnt signalling activation
drives homeostasis and damage-induced repair. Additionally, deregulated Wnt signalling is a
common hallmark of age-associated tissue dysfunction and cancer. Studies using mouse and fruit fly
models have greatly improved our understanding of the functional contribution of the Wnt signalling
pathway in adult intestinal biology. Here, we summarize the latest knowledge acquired from mouse
and Drosophila research regarding canonical Wnt signalling and its key functions during stem cell
driven intestinal homeostasis, regeneration, ageing and cancer.
Keywords: Wnt signalling; intestine; homeostasis; regeneration; stem cells; Drosophila; mouse
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1. Introduction
Wingless-related integration site (Wnt) was named after the Drosophila wingless gene and the
mouse int1 gene. Int1 was discovered in 1982 as a gene overexpressed in breast cancer [1]. Subsequent
studies revealed first the amino acid sequence and next demonstrated that Int1 was a secreted protein
with the potential to act as a signalling molecule [2,3]. Five years later, int1 was found to be homolog to
the Drosophila gene wingless (wg), which had been previously characterized as a segment polarity gene
through seminal work that identified regulators of body axis during embryonic development [4,5].
Thereafter, int/wingless became Wnt, giving also the generic name to the pathway itself, and Int1
became Wnt1 as the first ligand identified. More than three decades later, there are no doubts about the
importance of the Wnt pathway as an evolutionarily conserved system, which is broadly implicated in
diverse biological processes such as embryonic development, adult tissue homeostasis, regeneration
and disease [6–8].
The Wnt pathway is divided into β-catenin-dependent (canonical) and independent (non-canonical)
signalling. In both cases, the major components of the pathway are the Wnt ligands, which act in an
autocrine or paracrine fashion by binding their Frizzled (Fz) receptors. In canonical Wnt signalling,
Fz receptors engage with co-receptors Lrp5/6, at the cell surface. Here, we will focus on the canonical
pathway, as it is the one mainly studied in stem cell biology and the intestine. Briefly, in steady state
conditions, the levels of cytoplasmic β-catenin are kept low through phosphorylation by a complex of
proteins, known as the ‘destruction complex’, which includes Axin, Adenomatous polyposis coli (Apc),
glycogen synthase kinase 3 (Gsk3) and casein kinase 1α (Ck1α) [9]. This destruction complex promotes
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the ubiquitination of β-catenin and its degradation by the proteasome. Moreover, the ADP-ribose
polymerase Tankyrase (Tnks) has been described to target Axin and stimulate its degradation through
proteolysis [10]. Activation of the signalling pathway upon binding of Wnt ligands to receptors initiates
a series of signalling events, including the activation by phosphorylation of cytoplasmic Dishevelled
(Dsh), which ultimately leads to inactivation of the destruction complex and stabilization of β-catenin,
its accumulation in the cytosol and translocation into the nucleus where it forms complexes with Tcf/Lef
transcription factors, among others, to regulate target gene expression [8,11,12].
Work in the last two decades has demonstrated a central role of the Wnt pathway in the regulation
of adult stem cells and, hence, the maintenance of tissue homeostasis. Stem cells are highly dependent
on extrinsic cues derived from their microenvironment, also known as niche. Wnt signals are an essential
component of a wide range of stem cell niches, including that of the gastrointestinal epithelium [13,14].
The intestinal epithelium is constantly turned over through the action of dedicated intestinal
stem cells (ISCs). This process needs to be sustained and highly regulated as its disruption leads to
either tissue wasting or the development of gastrointestinal disorders, including cancer. In this review,
we will summarize the latest findings regarding the contribution of canonical Wnt signalling to ISCs
and their activity during normal tissue homeostasis, regeneration, ageing and intestinal cancer. We will
discuss data derived from studies in mice and the fruit fly Drosophila melanogaster, with an emphasis
on the use of the fly as an increasingly valuable model system and powerful genetic tool for studying
various aspects of Wnt signalling in intestinal health and pathogenesis.
2. The Adult Mammalian Intestine
The mammalian gut develops from the endoderm. During gastrulation the undifferentiated
endoderm is pre-patterned into three regions along the anterior–posterior axis: the foregut, which forms
the stomach and other organs; the midgut, which forms the small intestine; and the hindgut,
which gives rise to the large intestine [15]. The adult gastrointestinal tract is a tubular structure
composed of three layers consisting of smooth muscle, connective tissue and mucosa. The intestinal
epithelium is part of the mucosa layer, which is supported by the lamina propia and the muscularis
mucosae. The mucosa acts as a barrier, preventing the entry of harmful substances and exhibits both
innate and adaptive immune functions. It also acts as a selective filter, which enables the uptake of
nutrients, water, and various other beneficial materials from the intestinal lumen. From anterior to
posterior the mammalian intestinal tube is comprised of the small intestine, which is divided into
duodenum, jejunum, and ileum, and the large intestine, which consists of the cecum, colon and rectum.
The architecture of the small intestine is organised in a way that maximises the surface area available
for the absorption of nutrients. This is due to the presence of crypts of Lieberkühn and protrusions of
the epithelia known as villi (Figure 1i). The large intestine comprises a simple columnar epithelium
with crypts of Lieberkühn and a proliferative stem/progenitor zone. However, unlike the small
intestine, the large intestine lacks villi [16].
The mammalian intestine contains multipotent stem cells, which have the ability to self-renew
and generate undifferentiated transit amplifying cells and the various specialized cell types within the
intestinal epithelium, such as the absorptive enterocytes, secretory goblet cells, enteroendocrine cells
and Paneth cells (Figure 1i). One of the most notable advancements in the field of intestinal biology
has been the discovery of various populations of stem cells within the intestine, characterized by the
expression of specific markers, such as Lgr5 [17], Bmi1 [18], Musashi1 (Msi1) [19], Ascl2 [20] and Sox9 [21]
among others. Lgr5 is perhaps the most common marker used to target, functionally characterize and
lineage trace mammalian ISCs [17]. Lgr5 belongs to the G protein coupled receptor family and it is
one of 80 known Wnt target genes in the mammalian intestine [22,23]. ISCs were first discovered using
labeling with [3H] Thymidine following irradiation-induced damage of the tissue [24–26]. Studies using
this method were able to define the label retaining +4 position crypt cells as a population of slowly
cycling stem cells, which are distinct from the fast-cycling stem cells, also called crypt base columnar
cells (CBC) (Figure 1i). Crypt base columnar cells show active proliferation in response to homeostatic
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niche signals, while label-retaining cells remain quiescent during normal homeostasis and proliferate in
response to damage.
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Figure 1. Wnt signalling in the mammalian intestine during homeostasis, regeneration, ageing and
cancer. (i) Schematic of the cellular composition and architecture of a crypt–villi unit in the mammalian
intestine. The stroma is depicted in purple and the gut lumen in peach. The boxed area highlights the
crypt and stem cell niche, which are magnified in (ii–v); (ii) Main sources of the Wnt stem cell niche
and pathway activation during intestinal homeostasis. Wnt3 from Paneth cells, and Wnt and Rspo
from mesenchymal and epithelial stem cell niches are important sources of Wnt during homeostasis;
(iii) Sources of the Wnt stem cell niche and pathway activation during intestinal regeneration following
damage. Wnt2b signalling from intestinal epithelial cells is required to activate proliferation of quiescent
Tert + intestinal stem cells (ISCs). Wnt from macrophages and Wnt5a from the mesenchyme are also
important sources of Wnt during regeneration. Wnt activation of cMyc is known to target Fak and
Akt/mTOR pathways to increase ISC proliferation in response to damage; (iv) Reduced production
of mesenchymal and Paneth cell Wnt3 and canonical Wnt pathway activity in the ageing intestinal
epithelium impairs ISC proliferation; (v). Wnt pathway activation during intestinal tumourigenesis and
functional pathways activated following Apc loss. ISCs: intestinal stem cells; TA: transit amplifying
cells; Tert: telomerase reverse transcriptase; MF: mesenchymal fibroblasts; Apc: Adenomatous polyposis
coli; Fak: focal adhesion kinase; ROS: reactive oxygen species; TIGAR: TP53-inducible glycolysis and
apoptosis regulator; Rspo: R-Spondin; Sav1: Salvador 1; mTOR: mammalian target of rapamycin;
Yap1: Yes associated protein 1; Lats: Large tumour suppressor kinase 1; Nf-κβ: Nuclear factor κβ.
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Fast-cycling stem cells have generally been distinctly identified by their expression of the lgr5,
Olfm4 and Ascl2 genes, while slower cycling stem cells have been characterized by the expression
of markers including Bmi1, Lrig1, Hopx and telomerase reverse transcriptase (mTert) [18,27–32].
Nevertheless, recent studies using single cell RNA sequencing technology have revealed subpopulations
of cells that exhibit properties of both slow and fast cycling stem cells [33–35]. A subpopulation of
label-retaining cells acts as Lgr5 precursor cells that can regenerate the tissue upon damage [34], while a
subpopulation of Lgr5 stem cells co-expressing Mex3a also act as a slowly cycling reserve pool of stem
cells able to rapidly divide upon damage [35]. More work is needed to elucidate the role and regulation
of these cell populations.
Intestinal stem cells reside at the base of the crypt while most differentiated cells migrate up the
crypt–villus axis in the small intestine [36] with the exception of Paneth cells, an essential component
of the intestinal stem cell niche [37], which intercalate between ISCs at the crypt base (Figure 1i).
The distinct compartmentalization of stem cells from their differentiated linages, especially in the
small intestine, has been attributed to gradients of various signalling pathways along the crypt–villus
axis, including Wnt and EphB [22,38,39]. B-catenin and Tcf inversely control the expression of EphB2
and EphB3 receptors and their ligand Ephrin-B1 within the crypt–villus axis, which leads to higher
Eph signalling further from the crypt base. Experiments using EphB2/EphB3 null mice showed that
these genes are required to restrict cell intermingling and compartmentalize cell populations within
the intestinal epithelium [40].
3. The Adult Drosophila Intestine
The adult digestive tract of the fruit fly Drosophila melanogaster is a tubular structure surrounded
by visceral muscle, enteric neurons and gut-associated trachea, which are akin to the mammalian
vasculature. As it is the case for the mammalian intestine, the fly gut ensures essential physiological
functions of the living organism, such as the incorporation and processing of food, nutrient absorption
and elimination of solid waste, and displays key endocrine, immune and metabolic roles. The fly
intestine consists of a monolayer epithelium, divided into three domains of different developmental
origins: the foregut, the midgut, and the hindgut. The foregut and the hindgut epithelium are
of ectodermal origin whereas the midgut epithelium originates from the endoderm. The foregut
comprises the pharynx, the esophagus and the crop. The midgut extends from the cardia until the
junction with the hindgut, where the Malpighian tubules, which display functions similar to the
mammalian kidneys, connect with the gut. The Drosophila adult midgut is described to be the structural
and functional equivalent of the mammalian small intestine [17,41].
The fly midgut is replenished by ISCs [42,43]. Drosophila ISCs undergo cell division to renew
themselves and generate uncommitted enteroblasts (EBs), which are progenitor cells that can further
differentiate into either secretory enteroendocrine cells (EEs) or absorptive enterocytes (ECs) [44].
ISCs and EBs are characterized by the expression of the snail family transcription factor escargot (esg) [42]
and headcase (hdc) [45]. Drosophila ISCs do not reside within discrete anatomical locations equivalent to
the mammalian crypts and are instead scattered along the basal membrane of the intestinal epithelium.
However, they are in either direct or close contact with their microenvironment, which includes
uncommitted progenitor cells (EBs), differentiated midgut epithelial cells, visceral muscle (VM) and
trachea cells, which all constitute niches as they provide factors that regulate ISC self-renewal and
differentiation [46–52] (Figure 2i).
Due to the similarities between the Drosophila midgut and mammalian intestine and the relative
simplicity of the invertebrate model system, the adult fly midgut has become a powerful paradigm
for investigating the role of many conserved signalling pathways, including Wnt signalling, in the
regulation of ISC activity [51,53].
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Figure 2. Wnt signalling in the adult Drosophila midgut during home stasis, regeneration, a eing
and hyperplasia. (i) Schematic of the cellular composition and architecture of the adult Drosophila
midgut epithelium and its microenvironment; (ii) Main sources of the Wnt stem cell niche and pathway
activation during intestinal homeostasis. The VM and EBs produce Wg ligand to active signalling
within ISC and drive their proliferation. Wg signalling activation in ECs by Tnks and Ebd inhibit
ISC proliferation non-autonomously; (iii) Sources of the Wg stem cell niche and pathway activation
during intestinal regeneration following damage and upon ageing. Up-regulation of Wg from EBs
activates Wg sig alli g and its dow stream t rge dM c to drive ISC proliferation. The VM niche
expresses Wg but is dispensable for ISC proliferation in this context; (iv) Wnt pathway activation
during intestinal hyperplasia and functional pathways downstream of Apc. JNK and Yki activation
in Apc−/− cells drive ISC proliferation and cell competition leading to apoptosis of neighbouring
wild type cells. ISC: intestinal stem cell; EB: enteroblast; EC: enterocyte; ee: enteroendocrine cell;
BM: basement membrane; VM: visceral muscle; esg: escargot; hdc: headase; Wg: Wingless; Tnks: Tankyrase;
Ebd: Earthbound; Ewg: Erect wing; Yki: Yorkie; JNK: c-Jun N-terminal kinase; Upds: Unpaired
cytokines; EGFR: Epithelial growth factor receptor; JAK: Janus kinase.
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4. Wnt Signalling in Mammalian Intestinal Homeostasis and Regeneration
Initial evidence towards a central role of the Wnt pathway in intestinal-stem-cell homeostasis
came from pioneering studies in mice showing that genetic ablation of canonical Wnt singling
transcription factors Tcf-4 and β-catenin or the use of an inhibitor of the Wnt receptor, Dickkopf-related
protein 1 (Dkk1), abolished the proliferative capacity of the small intestine and led to severe disruption
of intestinal epithelial integrity, including the loss of crypts [54–59].
The discovery of Lgr5 as a stem cell marker [17] and the establishment of intestinal organoids
from purified crypts [60] represented a turning point in the study of ISC biology as it permitted,
amongst other things, targeted manipulation of genes within ISCs and the isolation of the intestinal
epithelium for in vitro studies. Single-sorted Lgr5 positive (Lgr5+ve) stem cells were first shown
to be able to produce an organised crypt–villus organoid structure in the absence of the epithelial
niche [60]. Later studies reported that the efficiency of organoid formation from single Lgr5+ve cells
was significantly increased by the addition of Paneth cells due to the provision of a Wnt niche [37].
The importance of an epithelial and mesenchymal Wnt-niche in the maintenance of stem cells in the
intestine has been recently challenged by a study reporting that impairment of Wnt secretion from
the intestinal epithelium or underlying smooth muscle through conditional knockout of porcupine
resulted in no obvious defects on intestinal epithelial structure, Wnt activation or the proliferative
rate of ISCs [61]. That study suggested a potential redundant nature of the Wnt stem cell niche in
the mammalian intestine, which was later confirmed by a recent report revealing intestinal defects
following global prevention of Wnt secretion through ubiquitous knockout of Wntless [62].
Lgr receptors potentiate Wnt signalling within ISCs following binding to the ligand, R-spondin.
R-spondin/Lgr binding leads to activation of downstream Wnt signalling through downregulation
of Fz specific E3 ubiquitin ligases Rnf43 and Znrf3 [63,64] (Figure 1ii). Impairment of Wnt signalling
by Rnf43 and Znrf3 suppresses proliferation in the intestine through ubiquitination and degradation
of surface-expressed Fz5 [63]. The receptor, Fz7 is also enriched in and required for ISC function in
the mammalian intestine [65]. Recent research has demonstrated the importance of a non-redundant
cooperation between R-spondin and Wnt signalling, by showing that Wnt proteins are required to
prime ISCs by maintaining R-spondin receptor expression, which then drives the further expansion of
stem cells via R-spondin ligands [66].
In addition to its function in intestinal homeostasis, Wnt signalling also plays a crucial role during
the regeneration of the mammalian intestine following injury. The intestinal epithelium can robustly
regenerate in response to multiple forms of stressors/damaging agents that disrupt the tissue, such as
cytotoxic drugs [67], gamma radiation [68], and following surgical resection [69]. Regeneration is
characterized by an increase in proliferation within the crypt compartment [70]. Multiple studies
show Wnt signalling activation as a key event in the induction of intestinal regeneration (Figure 1iii).
The Wnt target c-Myc is upregulated within the crypt compartment of the intestinal epithelium in
response to DNA damage and its activation is essential to induce intestinal regeneration through
focal adhesion kinase (Fak) and Akt/mTOR signalling [71]. Additionally, Wnt5a is expressed by
the stroma in response to intestinal damage and induces crypt regeneration in a TGFβ-dependent
manner [72]. Interestingly, Wnt produced by macrophages, a key constituent of the stroma, represents
an important component of the stem cell niche, which is required for intestinal regeneration and animal
survival following damage by irradiation [73]. More recently, damage-inducible Wnt2b expressed in
epithelial cells within the crypt has also been proven essential for the regeneration of the intestine upon
irradiation by stimulating proliferation of a subpopulation of quiescent Tert+ve ISCs [74] (Figure 1iii).
While conditional ablation of Tert+ve cells by diphtheria toxin A expression did not affect intestinal
homeostasis, it impaired tissue regeneration following injury [74]. Altogether, this evidence points to
the presence of multiple inducible, non-redundant Wnt ligand sources, which are essential for pathway
activation and the execution of intestinal regeneration.
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5. Wnt Signalling in Intestinal Homeostasis and Regeneration in Drosophila
In addition to the well-known general benefits offered by their short life cycle and large number
of offspring, there are at least two key advantages of using Drosophila for the study of Wnt signalling
in the intestine: the presence of genetic tools to individually label every cell types within the midgut,
and the low redundancy of Wnt ligands.
Multiple-redundant stem cell populations have been identified in mouse models [18,27–32,34,35,75].
Moreover, recent studies have highlighted the great plasticity in the mouse intestinal epithelium as
evidenced by the de-differentiation potential of committed lineages, including secretory progenitor
enterocytes [76], enteroendocrine cells [77] and Paneth cell precursors [78]. This regain of stemness in
order to re-populate the mouse intestine upon damage makes the pool of ‘reserve stem cell potential’
even larger and complicates studies of mammalian ISCs.
Functional studies of ISCs in the adult Drosophila midgut are less complex. The discovery of esg [42]
and, more recently, hdc [45] as markers of all stem/progenitor cells (ISCs/EBs), has allowed global
targeting of this cell population and unambiguous assessment of their role in intestinal homeostasis
and regeneration [45,79]. De-differentiation of committed lineages has not been reported in the
adult Drosophila midgut, suggesting a lower degree of plasticity or reserve stem cell potential in
the invertebrate tissue when compared to the mammalian intestine. However, recent studies have
reported the existence of cell division without mitotic spindle formation in polyploid ECs, also known
as amitosis, and plasticity in the rate of turnover of ECs as a means to maintain intestinal epithelial
homeostasis in conditions where stem cell pools are compromised [80,81].
There are multiple sources of Wnt ligands in the mammalian intestine (Table 1) [54,82], which has
complicated studies on the homeostatic Wnt stem cell niche [61,83–85]. However, low redundancy
in the function of Wnt ligands is revealed during intestinal regeneration upon damage [54,74,84].
Whether the differences between Wnt signalling activity in regeneration and homeostasis reflect the
activation of a distinct, ‘regeneration specific’ Wnt signature or different levels of signalling activity
required for each process remains to be addressed.
Table 1. List of fly and mammalian Wnts and their expression and function within the intestine.
Known fly and mammalian Wnt ligand genes and their expression status in the intestine as determined
by FlyGut-seq and NCBI, respectively. Reported intestinal function of Wnts is referenced.
Species Wnt Type VertebrateOrtholog
Intestinal
Expression Main Intestinal Function
Drosophila
Melanogaster
Wg Wnt1 + Required for intestinal homeostasis,regeneration and ageing [86,87]
Dwnt2 Wnt7 -
Dwnt3/5 Wnt5 -






Wnt2 + Intestinal development [88]
Wnt2b/13 + Secreted by sub epithelial and mesenchymalcells and essential for gut homeostasis [62]
Wnt3 +
Secreted from Paneth cells and essential for
stem cell maintenance [37,89]
Reduced expression in ageing ISCs [90]
Wnt3a - -
Wnt4 + Intestinal development [88]
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Table 1. Cont.
Species Wnt Type VertebrateOrtholog
Intestinal





Stromal macrophage induced expression
upon regeneration [73]
Colonic crypt regeneration [72]
Wnt5b + Intestinal development [88]
Wnt6 +
Intestinal development [88]
Transcriptionally upregulated upon damage
by irradiation in crypt epithelial cells [92]
Wnt7a - -
Wnt7b - -
Wnt8a + Intestinal development [88]
Wnt8b - -
Wnt9a + Suppressor of proliferation in CRC [93]





Expressed in adult intestine [94]
Wnt16 Low Unknown
The scenario concerning the Wnt stem cell niche in the Drosophila midgut appears simpler,
even though it shares similarities with its mammalian counterpart. Only Wingless (Wg) and Wnt4
appear to be expressed in the adult fly midgut (Table 1) and Wg is so far the only Wnt ligand reported
to have a functional role in the tissue (Table 1). Pioneering studies identified the visceral muscle (VM),
which surrounds the intestinal epithelium, as the main source of the Wg stem cell niche in homeostatic
conditions [86] (Figure 2ii). Global knockdown of wg or intestinal epithelial loss of genes encoding for
fz and fz2 receptors prevented homeostatic ISC self-renewal [86]. Further studies have described and
characterized novel sources of the Wg stem cell niche and additional roles of the pathway in intestinal
homeostasis and regeneration [87,95,96]. In addition to the visceral muscle, epithelial Wg is expressed
in the midgut–hindgut junction in homeostatic tissues. Here, Wnt pathway activation appears graded
along the length of the adult intestine, peaking at compartment boundaries [96]. Interestingly, work by
the same group has demonstrated that Wg pathway activation within ECs impairs ISC proliferation
non-autonomously during homeostasis [96,97] (Figure 2ii).
Wg expression by progenitor cells (EBs) is upregulated following damage to the intestinal
epithelium [87,95] (Figure 2iii). Cell-specific knockdown experiments have demonstrated that Wg
from EBs activates Wnt signalling and induction of the conserved pathway target dMyc within ISCs
to drive ISC proliferation upon damage (Figure 2iii). Importantly, while this source of the ligand is
essential to drive ISC proliferation and tissue regeneration in response to injury, it is dispensable for
homeostatic ISC self-renewal [87]. A strikingly similar phenomenon has been recently described for
Wnt2 in the mouse intestine [74] (Figure 1iii).
6. Wnt Signalling in Ageing and Tumorigenesis of the Mammalian Intestine
Aging is a complex process, which leads to a decline in tissue integrity and functionality. Ageing
affects stem cell function and, therefore, the regenerative capacity of self-renewing tissues. Persistent
expression of Wnt1 within the skin epidermis, which also contains Lgr5+ve stem cells, leads to senescence
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and exhaustion of the stem cell compartment through the sustained activation of mTOR, resulting in
a premature ageing phenotype [98]. Conversely, a decrease in canonical Wnt signalling upon ageing
results in reduced regenerative potential of the intestine (Figure 1iv). Wnt3 is reduced within stem cells
and their niches in the ageing intestine and the addition of the ligand to intestinal organoids of ageing
animals can restore ISC function [90]. This reduction of Wnt signalling in the aging intestine has been
proposed to represent a protective mechanism to counteract age-associated mutations that could cause
intestinal hyperproliferation. However, this also leads to an overall reduced regenerative potential of
ISCs upon ageing. Therefore, a full understanding of ageing-specific Wnt signalling events may lead to
the design of targeted therapies to prevent age-associated intestinal dysfunction without driving tissue
malignancies, such as cancer.
Wnt signalling is perhaps best known for its role as a key driver of intestinal cancer, typically
through loss of the negative regulator of the pathway Apc [99,100]. Apc is part of the destruction complex,
which counteracts pathway activation by targeting β-catenin for ubiquitination and degradation by
the proteasome [101]. Apc and CRC were first linked by the discovery and characterization of familial
adenomatous polyposis (FAP) [102,103], an inherited form of CRC characterized by mutations in the
Apc gene [104]. Apc is mutated in 80–90% of hereditary and spontaneous forms of colorectal cancer
(CRC) [105]. Over 60% of the mutations within Apc occur in the mutation cluster region (MCR) and
affect binding to Axin or β-catenin [106], which results in the accumulation of β-catenin and excessive
Wnt signalling. Although with lower incidence, CRC can also occur as a result of activating mutations
in the Ctnnb1 gene that encodes for β-catenin. Two independent Ctnnb1 mutations have been shown
to disrupt specific serine/threonine residues within β-catenin, which are normally subject to Gsk-3β
phosphorylation and required for subsequent protein degradation, thereby leading to accumulation of
β-catenin [106]. Loss of function mutations in components of the Wnt pathway, beyond Apc, have been
associated with CRC. Mutations in Rnf43 were found by whole exome sequencing in 18% of colorectal
adenomas, particularly in cases with high microsatellite instability (MSI-H) [107]. The Wilms tumour
suppressor (Wtx), a part of the β-catenin destruction complex, [108] is also mutated in colorectal tumours
with MSI-H [109]. However, in this article we will focus on CRC driven by Apc loss.
The study of Apc and its role in CRC was pioneered by the generation of genetically engineered
mouse models [110,111]. Conditional loss of function experiments showed that Apc is required for
cell proliferation and differentiation within the intestinal epithelium, as well as for the migration
of cells along the crypt–villus axis [111]. Later work assessing the contribution of ISCs to the
generation of intestinal tumours showed that knockdown of Apc within Lgr5+ve stem cells leads
to rapid intestinal adenoma formation. This work provided the first demonstration of a role of
ISCs as the cells of origin in CRC [112]. Complementarily, in vitro work showed that silencing Lgr5
leads to reduced cell proliferation, migration and the tumourigenic potential of colorectal cancer cell
lines [113]. Furthermore, high Lgr5 expression in cells derived from mouse tumours correlates with
strong upregulation of Wnt signalling [113]. However, work on genetically engineered mouse models
shows that ablation of Lgr5 stem cells within Apc-driven adenomas, is not sufficient to affect tumour
burden. Therefore, there may be multiple redundant cell populations, including Lgr5−ve ISCs, which
contribute to intestinal tumourigenesis [68].
Extensive work has been carried out to determine the mechanisms by which Apc loss drives
proliferation in CRC. For a comprehensive account of the literature on this subject, please see [114,115].
Our goal here is to highlight some key studies on the mechanisms driving intestinal hyperproliferation
following Apc loss from ISCs, as this is most directly related to the subject of this review (Figure 1v).
One such mechanism is mediated by activation of the Rac1 GTPase. Apc loss leads to myc activation,
which is in turn required to activate Rac1, leading to intestinal tumourigenesis via reactive oxygen
species (ROS) production and NF-κB signalling [116]. The TP53-inducible glycolysis and apoptosis
regulator (TIGAR), a protein involved in glucose metabolism, cooperates with Rac1 to drive
proliferation in response to Apc loss in the intestine [117] (Figure 1v).
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Activation of the non-receptor tyrosine kinase c-Src is increased by up to 15-fold in human
CRC [118]. Functional genetic studies in mice and Drosophila show that Src is required to induce
intestinal tumourigenesis and ISC proliferation following Apc loss [119]. Src activation in ISCs is
sufficient to drive intestinal hyperplasia, while conditional knock out of Apc and Src within Lgr5+ve
stem cells resulted in reduced tumour burden and increased animal survival [119] (Figure 1v).
Another pathway characterized as a downstream effector of Apc loss in the intestine includes
the Hippo signalling pathway, a conserved tumour suppressor pathway associated with CRC [120].
The transcription factor Yes-associated protein (Yap), which is normally inactivated by Hippo signalling,
is required for the formation of adenomas following loss of Apc. In this context, Apc acts as a
scaffold for Hippo pathway kinases Salvador (Sav1) and Large tumour suppressor kinase 1 (Lats) to
facilitate phosphorylation and subsequent degradation of Yap [121] (Figure 1v). An accompanying
article published in this special issue provides a comprehensive review of Wnt and Hippo signalling
interactions in the intestine [122].
The above-described studies support the ‘bottom up’ model of CRC, where loss of Apc in
the crypt/stem cell compartment is required to induce intestinal tumourigenesis. An opposing
model of CRC is the ‘top down’ model, which postulates that cells from the villi can also drive
intestinal transformation. Apc loss from the villi only is not sufficient for the generation of persistent
intestinal tumours [112,123]. However, combinations of Apc loss and activation of NF-κB induce
de-differentiation and drive tumorigenesis from villi [124]. A similar outcome is observed upon loss
of TGFβ, through inactivation of the TGFβ type 1 receptor in animals deficient for Apc and carrying
a constitutively active Kras mutation [125]. Further studies to better define the mechanisms through
which Wnt signalling drives intestinal tumourigenesis are vital to identify novel therapeutic targets
for CRC.
7. Wnt Signalling in Intestinal Hyperplasia and Ageing in Drosophila
Multiple studies have shown that the Drosophila midgut undergoes age-related dysfunction
of the intestinal epithelium, which is characterized by excessive ISC proliferation and aberrant
differentiation [126–129]. ISC proliferation dictates the global wellbeing of the organism and animal
lifespan [130]. Midgut epithelial Wg expression is induced upon ageing and drives age-dependent ISC
hyperproliferation through activation of its target dMyc within ISCs [87] (Figure 2iii). Critically, partial
knockdown of Wg or Myc prevents age-dependent intestinal hyperplasia without disrupting ISC
homeostasis [87], highlighting the potential benefits to the organism of maintaining controlled levels
of Wnt signalling activation in the intestine. Interestingly, a recent report reveals differences in the
way Wnt signalling is regulated in the ageing mouse and fly intestine. Unlike in flies, the ageing
mouse intestinal epithelium displays a reduced regenerative potential due to a decline in canonical
Wnt signalling [90] (Figure 1iv). It therefore appears that the ageing fly intestine is more similar to
ageing haematopoietic stem cells and the skin epidermis, which are also characterized by exacerbated
Wnt signaling [98,131,132], than to the ageing mouse intestine.
The adult Drosophila midgut has been successfully used to model various aspects of colorectal-cancer-
like hyperplasia. Over activation of Wnt signalling through overexpression of wg, activated β-catenin
or loss of Drosophila Apc leads to increased ISC proliferation and epithelial hyperplasia [86,133–135]
(Figure 2iv). Downregulation of dMyc or overexpression of dominant negative Tcf, suppresses
intestinal hyperplasia after Apc loss [133,135], suggesting the involvement of the canonical pathway
in this process. Recent work has revealed that two conserved suppressors of Drosophila Apc1,
earthbound (Ebd) and erect wing (Ewg) cooperate with β-catenin and Tcf to promote target gene
activation and intestinal hyperplasia following loss of Apc1 [97] (Figure 2iv). Ebd is known to
physically associate with and promote the formation and stability of the β-catenin–Tcf complex and the
recruitment of β-catenin to the chromatin [136]. Ewg is a DNA binding transcriptional activator that
shares DNA binding specificity with the human nuclear respiratory factor-1 (Nrf-1) [137]. The potential
role Nrf1, in mammalian Wnt signalling merits future investigation. Interestingly, Jerky (also known
Genes 2018, 9, 138 11 of 19
Jrk or Jh8), the human homolog of Ebd is detected at high levels in colon carcinoma and it is associated
with increased nuclear β-catenin and the overexpression of Wnt target genes in human colorectal
tumors [138].
Pathways mediating intestinal hyperproliferation downstream of Apc loss in Drosophila also
include the EGFR/MAPK and JAK/STAT signalling. Wg signalling regulates ISC proliferation
by inducing the production of ligands of the EGFR and JAK/STAT pathways in EBs and ECs
respectively [135]. This paracrine EGFR and JAK/STAT signalling crosstalk mediates intestinal
hyperproliferation following Wg overexpression and Apc1 loss. Moreover, Wnt signalling activates
the non-receptor tyrosine kinase c-Src (Src) in vivo [119]. Src drives tumourigenesis upon Apc loss in
the adult fly midgut through ISC upregulation of EGFR and JAK/STAT signalling [119] (Figure 2iv).
Lastly, as in mammals [120,121], Hippo signaling also mediates tumourigenesis of Apc deficient cells
(Apc−/−) in the adult fly midgut [139]. Interestingly, the work in Drosophila reveals tumor–host-cell
competition as an important determinant in the expansion of Apc−/− cells, which appears to involve
activation of the c-Jun N-terminal Kinase (JNK) and the Hippo signalling transcription factor Yorkie
(Yki) within Apc−/− cells, and apoptosis of the surrounding wild type cells [139] (Figure 2iv).
Further investigation of the role of Wg signalling in cell competition within the Drosophila midgut
could provide a new understanding on the pathology of Apc driven tumourigenesis in the intestine.
Oncogenic cooperation in CRC has also been modeled in Drosophila. Cooperation between
loss of Apc and hyperactivation of ras (Apc−/−, rasV12), which characterizes malignant stages of
human colorectal tumours [140,141], drives the progression of Apc mutant intestinal tumors and the
activation of Apc−/−, rasV12 specific transcriptional targets in the Drosophila adult midgut [142,143].
This paradigm should not only provide an excellent model to analyze the genetic events involved
in malignant tumor progression, but may also represent an attractive system to identify processes
specific to such genetic combinations and to test therapeutic agents. In fact, chemical compounds
have been successfully used in complex Drosophila models bearing combinations of various ‘CRC-like’
oncogenic mutations that generate invasive intestinal tumours derived from differentiated hindgut
cells, the functional equivalent of the mammalian colon [144]. Further use of the above-described
paradigms is likely to provide new insights into the functional molecular networks driving various
stages of CRC, which may contribute to the design of personalized therapeutics for the disease.
8. Conclusions and Perspectives
Many interesting questions remain to be addressed regarding the role of Wnt signalling in the
intestine and, in particular, in ISC function. Understanding the role of ‘regeneration specific’ Wnt
ligands, which are redundant for basal tissue homeostasis, is one of them. Studies in both mice and
Drosophila have evidenced the existence of damage-inducible Wnt stem cell niches that are specifically
needed to drive the acute proliferative response of ISCs following injury, but are dispensable for
homeostatic tissue self-renewal [71,87]. Intestinal regeneration shares many molecular features of
tumorigenesis [116,119]. Identification of the mechanisms activated by damage/stress-inducible
sources of Wnt ligands might represent an excellent therapeutic window for the targeting of Wnt-driven
intestinal hyperplasia while preserving organismal health.
Another interesting aspect of Wnt signalling in the intestine relates to the role of short range
signalling in the system. Pioneer work in Drosophila revealed that restriction of Wg secretion through
cell membrane tethering maintains cell growth functions of the ligand in the wing disc [145]. Later work
in the mammalian intestine presented evidence for short-range Wg signalling in stem cell proliferation
through membrane-tethered Wnt3 [89]. The extent of developmental and adult intestinal-specific
functions of such short range signalling remains largely unexplored. Drosophila is likely to provide
invaluable answers to this and other unexplored aspects of the regulation of intestinal health and
disease by Wnt signalling.
New, sophisticated mammalian CRC models are being successfully created through the use of
novel technologies such as CRISPR/Cas9. This includes the generation of mouse models carrying
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multiple gene mutations [146], metastatic CRC models [147–150], tools to trace cancer stem cells
in vivo [151] and complex gene editing within cultured intestinal organoids [152,153]. It will only be a
matter of time before the conservation of intricate molecular networks identified in Drosophila can be
assessed in such powerful mammalian paradigms.
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